US 9018356
Anti-ANGPTL3 antibodies and uses thereof
granted A61KA61K2039/505A61K31/455
Quick answer
US patent 9018356 (Anti-ANGPTL3 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K31/455, A61K39/3955, A61K45/06